Catalent (CTLT) - Stock Price & Dividends

Catalent, Inc., and its subsidiaries work worldwide to develop and produce solutions for various industries like drugs, protein-based biologics, cell and gene therapies, and consumer health products. It operates through two main segments, namely the Biologics segment and the Pharma and Consumer Health segment.

The Biologics segment focuses on offering a wide range of services, including formulation, development, and manufacturing for biologic proteins, cell gene, and other nucleic acid therapies. This segment also provides analytical development and testing services for large molecules and various dose forms like vials, prefilled syringes, and cartridges.

On the other hand, the Pharma and Consumer Health segment specialize in formulating, developing, and producing soft capsules for different customer products, such as prescription drugs, dietary supplements, cosmetics, and animal health medicines. This segment also provides various clinical supply services and manufacturing operations for small-molecule drugs and biologics during clinical trials.

Furthermore, Catalent, Inc. offers innovative solutions like FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions. Additionally, the company provides integrated development and product supply chain solutions to meet the diverse needs of the pharmaceutical, biotechnology, consumer health, and other healthcare market segments.

Founded in 1933 and headquartered in Somerset, New Jersey, Catalent, Inc. serves a wide range of industries, including pharmaceuticals, biotechnology, consumer health, animal health, medical devices, and cosmetics.

For more information about Catalent, Inc., you can visit their website at https://www.catalent.com.